Posted Sep 30, 2026

Senior Director/Director - Regulatory CMC

Apply Now
Director / Senior Director, Regulatory CMC Full-Time | Fully Remote | United States About the Role A growing clinical-stage biopharmaceutical company is seeking an experienced Director / Senior Director, Regulatory CMC to lead regulatory strategy and execution for CMC activities across its development portfolio. This is a highly visible role for an experienced regulatory professional who can provide strategic guidance across CMC development, regulatory submissions, and interactions with health authorities. The successful candidate will work closely with CMC, Quality, R&D, Clinical, and other cross-functional teams to ensure regulatory requirements are incorporated into development plans and submissions. The ideal candidate brings strong hands-on CMC regulatory expertise, sound judgment, and the ability to operate effectively in a fast-paced, collaborative environment. Key Responsibilities • Develop and execute global regulatory CMC strategies supporting clinical development, registration, and product lifecycle activities. • Lead the preparation, review, and submission of CMC content for regulatory filings, including INDs, IMPDs, NDAs, BLAs, and related supplements and amendments. • Provide regulatory guidance on CMC development activities, including manufacturing processes, analytical methods, formulation, scale-up, process changes, and technology transfers. • Assess regulatory implications of proposed manufacturing and quality changes and recommend appropriate regulatory pathways. • Partner with CMC, Quality, R&D, Clinical, and other functional teams to establish regulatory strategies and maintain submission readiness. • Serve as the regulatory CMC lead for interactions with FDA, EMA, and other global health authorities. • Prepare teams for regulatory meetings and provide CMC expertise during agency interactions, including pre-IND, end-of-phase, and pre-submission meetings. • Monitor evolving FDA, EMA, ICH, and other applicable CMC regulations and guidance and translate changes into actionable development strategies. • Support regulatory planning across multiple programs and manage priorities in a dynamic development environment. • Provide oversight and direction to external consultants, CROs, and other regulatory partners as needed. • Communicate complex regulatory considerations clearly to senior leadership and cross-functional stakeholders. Qualifications • Bachelor's degree in Chemistry, Pharmacy, Pharmaceutical Sciences, Life Sciences, or a related discipline required; advanced degree such as an MS, PharmD, or PhD preferred. • 10+ years of progressive experience in CMC Regulatory Affairs within the pharmaceutical or biotechnology industry. • Strong experience supporting small-molecule drug development, preferably within oncology or another complex therapeutic area. • Demonstrated experience developing and executing CMC regulatory strategies for clinical-stage programs. • Track record of contributing to successful regulatory submissions and approvals in the United States and, ideally, international markets. • Strong working knowledge of FDA, EMA, and ICH CMC requirements and guidance. • Experience authoring, reviewing, and managing CMC sections of regulatory submissions. • Experience working directly with cross-functional CMC, Quality, Manufacturing, and R&D organizations. • Strong understanding of regulatory considerations related to manufacturing, process development, analytical development, formulation, and product changes. • Excellent communication, organizational, and project-management skills. • Ability to influence cross-functional teams and effectively manage external partners. • Comfortable working independently and taking ownership in a fast-moving, development-focused environment. What the Company Offers • Fully remote position • Opportunity to play a key regulatory role within a growing clinical-stage biotechnology organization • High visibility and close collaboration with CMC, Quality, R&D, and senior leadership • Opportunity to shape regulatory strategy across an evolving development portfolio • Competitive benefits and equity participation